ICU Medical and VisionHealth Launch MyAcapella^™ OPEP Digital Coach to Improve OPEP Therapy and Adherence for Respiratory Patients

New digital coaching app enhances patient experience and clinician oversight through guided therapy, reminders, and adherence tracking.

San Clemente, Calif. May 15, 2025 – ICU Medical Inc. (NASDAQ:ICUI), in collaboration with VisionHealth GmbH, has announced the launch of MyAcapella, a mobile application designed to support Oscillating Positive Expiratory Pressure (OPEP) therapy for patients with chronic respiratory conditions. The new app, now available for download, offers guided coaching, therapy reminders, patient education, and adherence tracking—aiming to reduce patient non-compliance and simplify clinician monitoring.

OPEP therapy is commonly prescribed for individuals with chronic respiratory conditions including COPD, bronchiectasis, and cystic fibrosis. However, clinicians often face obstacles like constrained training time and limited insight into patient adherence between follow-up appointments. Patients, in turn, can be uncertain about proper device technique, have gaps in education, and struggle to keep up with daily sessions—factors that can undermine the effectiveness of airway clearance therapy.

MyAcapella aims to close these gaps by delivering:

• Step-by-Step Coaching: Animated, audible guidance so patients can perform OPEP exercises correctly and confidently.
• Automated Reminders: Notifications and calendar-based session scheduling that prompt patients to complete therapy on time.
• Progress Tracking & Reports: A built-in adherence score and a weekly performance overview that can be downloaded as a PDF by the patient to share with their clinician for review.
• Educational Resources: Instructions on proper device cleaning, huff coughing techniques, and reputable patient support organizations.

From a clinician’s perspective, MyAcapella helps maintain treatment accuracy and streamlines training, thanks to its clear guidance tools. It also allows for ongoing collaboration by letting patients share adherence data remotely. This visibility supports timely intervention and potentially reduces readmissions linked to poor airway clearance.

"MyAcapella enhances therapy by reinforcing correct technique and providing real-time adherence insights,” said Henrik Schwerdt, Vice President of Respiratory and Critical Care at ICU Medical. “This digital coach not only empowers patients to take ownership of their health but also offers clinicians a practical way to monitor therapy completion and adjust care plans as needed."

The app follows a straightforward roadmap for improved airway collaboration: after the clinician prescribes OPEP therapy, the patient downloads MyAcapella, receives guided scheduling, and ultimately shares adherence reports back to the care team. This self-management model helps alleviate the burden on clinicians while reinforcing consistent and accurate therapy at home.

MyAcapella was developed jointly by ICU Medical, a leading medical technology company, and VisionHealth, a health tech company specializing in digital solutions for respiratory care. The app reflects combined expertise in respiratory care innovation.

The app is available for download today.